Sartorius Stedim Biotech SA Stock Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
Sales 2024 * | 2.94B 3.17B | Sales 2025 * | 3.35B 3.61B | Capitalization | 20.02B 21.56B |
---|---|---|---|---|---|
Net income 2024 * | 343M 369M | Net income 2025 * | 459M 494M | EV / Sales 2024 * | 7.58 x |
Net Debt 2024 * | 2.27B 2.44B | Net Debt 2025 * | 2.15B 2.32B | EV / Sales 2025 * | 6.62 x |
P/E ratio 2024 * |
57
x | P/E ratio 2025 * |
41.1
x | Employees | - |
Yield 2024 * |
0.36% | Yield 2025 * |
0.54% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock